ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Angiogenesis Modulators Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-20Y9410
Home | Market Reports | Health| Pharmacy
Global Angiogenesis Modulators Market Insights and Forecast to 2028
BUY CHAPTERS

Global Angiogenesis Modulators Market Research Report 2025

Code: QYRE-Auto-20Y9410
Report
September 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Celgene Corporation (USA)
Eisai (Japan)
Amgen, Inc. (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Bayer Pharma AG (Germany)
Bionomics Ltd. (Australia)
CASI Pharmaceuticals, Inc. (USA)
AstraZeneca Plc. (UK)
Eli Lilly and Company (USA)
F Hoffmann-La Roche AG (Switzerland)

Angiogenesis Modulators Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Angiogenesis Modulators Market

Angiogenesis Modulators Market

The global market for Angiogenesis Modulators was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Angiogenesis Modulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiogenesis Modulators.
The Angiogenesis Modulators market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Angiogenesis Modulators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Angiogenesis Modulators manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Angiogenesis Modulators Market Report

Report Metric Details
Report Name Angiogenesis Modulators Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Celgene Corporation (USA), Eisai (Japan), Amgen, Inc. (USA), Genentech, Inc. (USA), GlaxoSmithKline plc (UK), Bayer Pharma AG (Germany), Bionomics Ltd. (Australia), CASI Pharmaceuticals, Inc. (USA), AstraZeneca plc (UK), Eli Lilly and Company (USA), F.Hoffmann-La Roche AG (Switzerland)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Angiogenesis Modulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Angiogenesis Modulators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Angiogenesis Modulators Market report?

Ans: The main players in the Angiogenesis Modulators Market are Celgene Corporation (USA), Eisai (Japan), Amgen, Inc. (USA), Genentech, Inc. (USA), GlaxoSmithKline plc (UK), Bayer Pharma AG (Germany), Bionomics Ltd. (Australia), CASI Pharmaceuticals, Inc. (USA), AstraZeneca plc (UK), Eli Lilly and Company (USA), F.Hoffmann-La Roche AG (Switzerland)

What are the Application segmentation covered in the Angiogenesis Modulators Market report?

Ans: The Applications covered in the Angiogenesis Modulators Market report are Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Others

What are the Type segmentation covered in the Angiogenesis Modulators Market report?

Ans: The Types covered in the Angiogenesis Modulators Market report are Angiogenesis Inhibitors, Angiogenesis Stimulators, Angiogenin, Others

Recommended Reports

Cardiovascular Devices

Medical Imaging

Therapeutic Solutions

1 Angiogenesis Modulators Market Overview
1.1 Product Definition
1.2 Angiogenesis Modulators by Type
1.2.1 Global Angiogenesis Modulators Market Value Comparison by Type (2024 VS 2031)
1.2.2 Angiogenesis Inhibitors
1.2.3 Angiogenesis Stimulators
1.2.4 Angiogenin
1.2.5 Others
1.3 Angiogenesis Modulators by Application
1.3.1 Global Angiogenesis Modulators Market Value by Application (2024 VS 2031)
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Lung Cancer
1.3.5 Prostate Cancer
1.3.6 Others
1.4 Global Angiogenesis Modulators Market Size Estimates and Forecasts
1.4.1 Global Angiogenesis Modulators Revenue 2020-2031
1.4.2 Global Angiogenesis Modulators Sales 2020-2031
1.4.3 Global Angiogenesis Modulators Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Angiogenesis Modulators Market Competition by Manufacturers
2.1 Global Angiogenesis Modulators Sales Market Share by Manufacturers (2020-2025)
2.2 Global Angiogenesis Modulators Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Angiogenesis Modulators Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Angiogenesis Modulators, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Angiogenesis Modulators, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Angiogenesis Modulators, Product Type & Application
2.7 Global Key Manufacturers of Angiogenesis Modulators, Date of Enter into This Industry
2.8 Global Angiogenesis Modulators Market Competitive Situation and Trends
2.8.1 Global Angiogenesis Modulators Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Angiogenesis Modulators Players Market Share by Revenue
2.8.3 Global Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Angiogenesis Modulators Market Scenario by Region
3.1 Global Angiogenesis Modulators Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Angiogenesis Modulators Sales by Region: 2020-2031
3.2.1 Global Angiogenesis Modulators Sales by Region: 2020-2025
3.2.2 Global Angiogenesis Modulators Sales by Region: 2026-2031
3.3 Global Angiogenesis Modulators Revenue by Region: 2020-2031
3.3.1 Global Angiogenesis Modulators Revenue by Region: 2020-2025
3.3.2 Global Angiogenesis Modulators Revenue by Region: 2026-2031
3.4 North America Angiogenesis Modulators Market Facts & Figures by Country
3.4.1 North America Angiogenesis Modulators Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Angiogenesis Modulators Sales by Country (2020-2031)
3.4.3 North America Angiogenesis Modulators Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Angiogenesis Modulators Market Facts & Figures by Country
3.5.1 Europe Angiogenesis Modulators Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Angiogenesis Modulators Sales by Country (2020-2031)
3.5.3 Europe Angiogenesis Modulators Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Angiogenesis Modulators Market Facts & Figures by Region
3.6.1 Asia Pacific Angiogenesis Modulators Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Angiogenesis Modulators Sales by Region (2020-2031)
3.6.3 Asia Pacific Angiogenesis Modulators Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Angiogenesis Modulators Market Facts & Figures by Country
3.7.1 Latin America Angiogenesis Modulators Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Angiogenesis Modulators Sales by Country (2020-2031)
3.7.3 Latin America Angiogenesis Modulators Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Angiogenesis Modulators Market Facts & Figures by Country
3.8.1 Middle East and Africa Angiogenesis Modulators Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Angiogenesis Modulators Sales by Country (2020-2031)
3.8.3 Middle East and Africa Angiogenesis Modulators Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Angiogenesis Modulators Sales by Type (2020-2031)
4.1.1 Global Angiogenesis Modulators Sales by Type (2020-2025)
4.1.2 Global Angiogenesis Modulators Sales by Type (2026-2031)
4.1.3 Global Angiogenesis Modulators Sales Market Share by Type (2020-2031)
4.2 Global Angiogenesis Modulators Revenue by Type (2020-2031)
4.2.1 Global Angiogenesis Modulators Revenue by Type (2020-2025)
4.2.2 Global Angiogenesis Modulators Revenue by Type (2026-2031)
4.2.3 Global Angiogenesis Modulators Revenue Market Share by Type (2020-2031)
4.3 Global Angiogenesis Modulators Price by Type (2020-2031)
5 Segment by Application
5.1 Global Angiogenesis Modulators Sales by Application (2020-2031)
5.1.1 Global Angiogenesis Modulators Sales by Application (2020-2025)
5.1.2 Global Angiogenesis Modulators Sales by Application (2026-2031)
5.1.3 Global Angiogenesis Modulators Sales Market Share by Application (2020-2031)
5.2 Global Angiogenesis Modulators Revenue by Application (2020-2031)
5.2.1 Global Angiogenesis Modulators Revenue by Application (2020-2025)
5.2.2 Global Angiogenesis Modulators Revenue by Application (2026-2031)
5.2.3 Global Angiogenesis Modulators Revenue Market Share by Application (2020-2031)
5.3 Global Angiogenesis Modulators Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Celgene Corporation (USA)
6.1.1 Celgene Corporation (USA) Company Information
6.1.2 Celgene Corporation (USA) Description and Business Overview
6.1.3 Celgene Corporation (USA) Angiogenesis Modulators Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Celgene Corporation (USA) Angiogenesis Modulators Product Portfolio
6.1.5 Celgene Corporation (USA) Recent Developments/Updates
6.2 Eisai (Japan)
6.2.1 Eisai (Japan) Company Information
6.2.2 Eisai (Japan) Description and Business Overview
6.2.3 Eisai (Japan) Angiogenesis Modulators Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eisai (Japan) Angiogenesis Modulators Product Portfolio
6.2.5 Eisai (Japan) Recent Developments/Updates
6.3 Amgen, Inc. (USA)
6.3.1 Amgen, Inc. (USA) Company Information
6.3.2 Amgen, Inc. (USA) Description and Business Overview
6.3.3 Amgen, Inc. (USA) Angiogenesis Modulators Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Amgen, Inc. (USA) Angiogenesis Modulators Product Portfolio
6.3.5 Amgen, Inc. (USA) Recent Developments/Updates
6.4 Genentech, Inc. (USA)
6.4.1 Genentech, Inc. (USA) Company Information
6.4.2 Genentech, Inc. (USA) Description and Business Overview
6.4.3 Genentech, Inc. (USA) Angiogenesis Modulators Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Genentech, Inc. (USA) Angiogenesis Modulators Product Portfolio
6.4.5 Genentech, Inc. (USA) Recent Developments/Updates
6.5 GlaxoSmithKline plc (UK)
6.5.1 GlaxoSmithKline plc (UK) Company Information
6.5.2 GlaxoSmithKline plc (UK) Description and Business Overview
6.5.3 GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Portfolio
6.5.5 GlaxoSmithKline plc (UK) Recent Developments/Updates
6.6 Bayer Pharma AG (Germany)
6.6.1 Bayer Pharma AG (Germany) Company Information
6.6.2 Bayer Pharma AG (Germany) Description and Business Overview
6.6.3 Bayer Pharma AG (Germany) Angiogenesis Modulators Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bayer Pharma AG (Germany) Angiogenesis Modulators Product Portfolio
6.6.5 Bayer Pharma AG (Germany) Recent Developments/Updates
6.7 Bionomics Ltd. (Australia)
6.7.1 Bionomics Ltd. (Australia) Company Information
6.7.2 Bionomics Ltd. (Australia) Description and Business Overview
6.7.3 Bionomics Ltd. (Australia) Angiogenesis Modulators Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bionomics Ltd. (Australia) Angiogenesis Modulators Product Portfolio
6.7.5 Bionomics Ltd. (Australia) Recent Developments/Updates
6.8 CASI Pharmaceuticals, Inc. (USA)
6.8.1 CASI Pharmaceuticals, Inc. (USA) Company Information
6.8.2 CASI Pharmaceuticals, Inc. (USA) Description and Business Overview
6.8.3 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Portfolio
6.8.5 CASI Pharmaceuticals, Inc. (USA) Recent Developments/Updates
6.9 AstraZeneca plc (UK)
6.9.1 AstraZeneca plc (UK) Company Information
6.9.2 AstraZeneca plc (UK) Description and Business Overview
6.9.3 AstraZeneca plc (UK) Angiogenesis Modulators Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AstraZeneca plc (UK) Angiogenesis Modulators Product Portfolio
6.9.5 AstraZeneca plc (UK) Recent Developments/Updates
6.10 Eli Lilly and Company (USA)
6.10.1 Eli Lilly and Company (USA) Company Information
6.10.2 Eli Lilly and Company (USA) Description and Business Overview
6.10.3 Eli Lilly and Company (USA) Angiogenesis Modulators Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Eli Lilly and Company (USA) Angiogenesis Modulators Product Portfolio
6.10.5 Eli Lilly and Company (USA) Recent Developments/Updates
6.11 F.Hoffmann-La Roche AG (Switzerland)
6.11.1 F.Hoffmann-La Roche AG (Switzerland) Company Information
6.11.2 F.Hoffmann-La Roche AG (Switzerland) Description and Business Overview
6.11.3 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales, Revenue and Gross Margin (2020-2025)
6.11.4 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Portfolio
6.11.5 F.Hoffmann-La Roche AG (Switzerland) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Angiogenesis Modulators Industry Chain Analysis
7.2 Angiogenesis Modulators Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Angiogenesis Modulators Production Mode & Process Analysis
7.4 Angiogenesis Modulators Sales and Marketing
7.4.1 Angiogenesis Modulators Sales Channels
7.4.2 Angiogenesis Modulators Distributors
7.5 Angiogenesis Modulators Customer Analysis
8 Angiogenesis Modulators Market Dynamics
8.1 Angiogenesis Modulators Industry Trends
8.2 Angiogenesis Modulators Market Drivers
8.3 Angiogenesis Modulators Market Challenges
8.4 Angiogenesis Modulators Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Celgene Corporation (USA)
Eisai (Japan)
Amgen, Inc. (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Bayer Pharma AG (Germany)
Bionomics Ltd. (Australia)
CASI Pharmaceuticals, Inc. (USA)
AstraZeneca Plc. (UK)
Eli Lilly and Company (USA)
F Hoffmann-La Roche AG (Switzerland)
List of Tables
 Table 1. Global Angiogenesis Modulators Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Angiogenesis Modulators Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Angiogenesis Modulators Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Angiogenesis Modulators Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Angiogenesis Modulators Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Angiogenesis Modulators Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Angiogenesis Modulators Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Angiogenesis Modulators Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Angiogenesis Modulators, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Angiogenesis Modulators, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Angiogenesis Modulators, Product Type & Application
 Table 12. Global Key Manufacturers of Angiogenesis Modulators, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Angiogenesis Modulators by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiogenesis Modulators as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Angiogenesis Modulators Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Angiogenesis Modulators Sales by Region (2020-2025) & (K MT)
 Table 18. Global Angiogenesis Modulators Sales Market Share by Region (2020-2025)
 Table 19. Global Angiogenesis Modulators Sales by Region (2026-2031) & (K MT)
 Table 20. Global Angiogenesis Modulators Sales Market Share by Region (2026-2031)
 Table 21. Global Angiogenesis Modulators Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Angiogenesis Modulators Revenue Market Share by Region (2020-2025)
 Table 23. Global Angiogenesis Modulators Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Angiogenesis Modulators Revenue Market Share by Region (2026-2031)
 Table 25. North America Angiogenesis Modulators Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Angiogenesis Modulators Sales by Country (2020-2025) & (K MT)
 Table 27. North America Angiogenesis Modulators Sales by Country (2026-2031) & (K MT)
 Table 28. North America Angiogenesis Modulators Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Angiogenesis Modulators Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Angiogenesis Modulators Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Angiogenesis Modulators Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Angiogenesis Modulators Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Angiogenesis Modulators Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Angiogenesis Modulators Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Angiogenesis Modulators Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Angiogenesis Modulators Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Angiogenesis Modulators Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Angiogenesis Modulators Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Angiogenesis Modulators Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Angiogenesis Modulators Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Angiogenesis Modulators Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Angiogenesis Modulators Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Angiogenesis Modulators Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Angiogenesis Modulators Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Angiogenesis Modulators Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Angiogenesis Modulators Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Angiogenesis Modulators Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Angiogenesis Modulators Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Angiogenesis Modulators Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Angiogenesis Modulators Sales (K MT) by Type (2020-2025)
 Table 51. Global Angiogenesis Modulators Sales (K MT) by Type (2026-2031)
 Table 52. Global Angiogenesis Modulators Sales Market Share by Type (2020-2025)
 Table 53. Global Angiogenesis Modulators Sales Market Share by Type (2026-2031)
 Table 54. Global Angiogenesis Modulators Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Angiogenesis Modulators Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Angiogenesis Modulators Revenue Market Share by Type (2020-2025)
 Table 57. Global Angiogenesis Modulators Revenue Market Share by Type (2026-2031)
 Table 58. Global Angiogenesis Modulators Price (USD/MT) by Type (2020-2025)
 Table 59. Global Angiogenesis Modulators Price (USD/MT) by Type (2026-2031)
 Table 60. Global Angiogenesis Modulators Sales (K MT) by Application (2020-2025)
 Table 61. Global Angiogenesis Modulators Sales (K MT) by Application (2026-2031)
 Table 62. Global Angiogenesis Modulators Sales Market Share by Application (2020-2025)
 Table 63. Global Angiogenesis Modulators Sales Market Share by Application (2026-2031)
 Table 64. Global Angiogenesis Modulators Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Angiogenesis Modulators Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Angiogenesis Modulators Revenue Market Share by Application (2020-2025)
 Table 67. Global Angiogenesis Modulators Revenue Market Share by Application (2026-2031)
 Table 68. Global Angiogenesis Modulators Price (USD/MT) by Application (2020-2025)
 Table 69. Global Angiogenesis Modulators Price (USD/MT) by Application (2026-2031)
 Table 70. Celgene Corporation (USA) Company Information
 Table 71. Celgene Corporation (USA) Description and Business Overview
 Table 72. Celgene Corporation (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Celgene Corporation (USA) Angiogenesis Modulators Product
 Table 74. Celgene Corporation (USA) Recent Developments/Updates
 Table 75. Eisai (Japan) Company Information
 Table 76. Eisai (Japan) Description and Business Overview
 Table 77. Eisai (Japan) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Eisai (Japan) Angiogenesis Modulators Product
 Table 79. Eisai (Japan) Recent Developments/Updates
 Table 80. Amgen, Inc. (USA) Company Information
 Table 81. Amgen, Inc. (USA) Description and Business Overview
 Table 82. Amgen, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Amgen, Inc. (USA) Angiogenesis Modulators Product
 Table 84. Amgen, Inc. (USA) Recent Developments/Updates
 Table 85. Genentech, Inc. (USA) Company Information
 Table 86. Genentech, Inc. (USA) Description and Business Overview
 Table 87. Genentech, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Genentech, Inc. (USA) Angiogenesis Modulators Product
 Table 89. Genentech, Inc. (USA) Recent Developments/Updates
 Table 90. GlaxoSmithKline plc (UK) Company Information
 Table 91. GlaxoSmithKline plc (UK) Description and Business Overview
 Table 92. GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. GlaxoSmithKline plc (UK) Angiogenesis Modulators Product
 Table 94. GlaxoSmithKline plc (UK) Recent Developments/Updates
 Table 95. Bayer Pharma AG (Germany) Company Information
 Table 96. Bayer Pharma AG (Germany) Description and Business Overview
 Table 97. Bayer Pharma AG (Germany) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Bayer Pharma AG (Germany) Angiogenesis Modulators Product
 Table 99. Bayer Pharma AG (Germany) Recent Developments/Updates
 Table 100. Bionomics Ltd. (Australia) Company Information
 Table 101. Bionomics Ltd. (Australia) Description and Business Overview
 Table 102. Bionomics Ltd. (Australia) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Bionomics Ltd. (Australia) Angiogenesis Modulators Product
 Table 104. Bionomics Ltd. (Australia) Recent Developments/Updates
 Table 105. CASI Pharmaceuticals, Inc. (USA) Company Information
 Table 106. CASI Pharmaceuticals, Inc. (USA) Description and Business Overview
 Table 107. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product
 Table 109. CASI Pharmaceuticals, Inc. (USA) Recent Developments/Updates
 Table 110. AstraZeneca plc (UK) Company Information
 Table 111. AstraZeneca plc (UK) Description and Business Overview
 Table 112. AstraZeneca plc (UK) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. AstraZeneca plc (UK) Angiogenesis Modulators Product
 Table 114. AstraZeneca plc (UK) Recent Developments/Updates
 Table 115. Eli Lilly and Company (USA) Company Information
 Table 116. Eli Lilly and Company (USA) Description and Business Overview
 Table 117. Eli Lilly and Company (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. Eli Lilly and Company (USA) Angiogenesis Modulators Product
 Table 119. Eli Lilly and Company (USA) Recent Developments/Updates
 Table 120. F.Hoffmann-La Roche AG (Switzerland) Company Information
 Table 121. F.Hoffmann-La Roche AG (Switzerland) Description and Business Overview
 Table 122. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product
 Table 124. F.Hoffmann-La Roche AG (Switzerland) Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Angiogenesis Modulators Distributors List
 Table 128. Angiogenesis Modulators Customers List
 Table 129. Angiogenesis Modulators Market Trends
 Table 130. Angiogenesis Modulators Market Drivers
 Table 131. Angiogenesis Modulators Market Challenges
 Table 132. Angiogenesis Modulators Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Angiogenesis Modulators
 Figure 2. Global Angiogenesis Modulators Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Angiogenesis Modulators Market Share by Type: 2024 & 2031
 Figure 4. Angiogenesis Inhibitors Product Picture
 Figure 5. Angiogenesis Stimulators Product Picture
 Figure 6. Angiogenin Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Angiogenesis Modulators Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Angiogenesis Modulators Market Share by Application: 2024 & 2031
 Figure 10. Breast Cancer
 Figure 11. Colorectal Cancer
 Figure 12. Lung Cancer
 Figure 13. Prostate Cancer
 Figure 14. Others
 Figure 15. Global Angiogenesis Modulators Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Angiogenesis Modulators Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Angiogenesis Modulators Sales (2020-2031) & (K MT)
 Figure 18. Global Angiogenesis Modulators Average Price (USD/MT) & (2020-2031)
 Figure 19. Angiogenesis Modulators Report Years Considered
 Figure 20. Angiogenesis Modulators Sales Share by Manufacturers in 2024
 Figure 21. Global Angiogenesis Modulators Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Angiogenesis Modulators Players: Market Share by Revenue in Angiogenesis Modulators in 2024
 Figure 23. Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Angiogenesis Modulators Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Angiogenesis Modulators Sales Market Share by Country (2020-2031)
 Figure 26. North America Angiogenesis Modulators Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Angiogenesis Modulators Sales Market Share by Country (2020-2031)
 Figure 30. Europe Angiogenesis Modulators Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Angiogenesis Modulators Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Angiogenesis Modulators Revenue Market Share by Region (2020-2031)
 Figure 38. China Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America Angiogenesis Modulators Sales Market Share by Country (2020-2031)
 Figure 49. Latin America Angiogenesis Modulators Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa Angiogenesis Modulators Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Angiogenesis Modulators Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE Angiogenesis Modulators Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of Angiogenesis Modulators by Type (2020-2031)
 Figure 59. Global Revenue Market Share of Angiogenesis Modulators by Type (2020-2031)
 Figure 60. Global Angiogenesis Modulators Price (USD/MT) by Type (2020-2031)
 Figure 61. Global Sales Market Share of Angiogenesis Modulators by Application (2020-2031)
 Figure 62. Global Revenue Market Share of Angiogenesis Modulators by Application (2020-2031)
 Figure 63. Global Angiogenesis Modulators Price (USD/MT) by Application (2020-2031)
 Figure 64. Angiogenesis Modulators Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Cancer Angiogenesis Inhibitors Market Research Report 2024
Global Antiangiogenic Agent Market Research Report 2025
Global Angiographic Interventional Therapy System Market Research Report 2025
Global Translational Regenerative Medicine Market Insights Forecast to 2030
Global Interventional Cardiovascular Device Market Research Report 2025
Global Vascular Interventional Apparatus Market Insights Forecast to 2030
Vascular Endothelial Growth Factor Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Angiography Machine Market Research Report 2025
Global Medical Angiography Devices Market Insights Forecast to 2030
Global Cell Regeneration Medicine Market Research Report 2024
Global Polymer Material Artificial Blood Vessel Market Research Report 2024
Angiocatheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vascular Interventional Robot Market Research Report 2025
Global Coronary Artery Disease Medical Devices Market Research Report 2024
Healthcare Revenue Cycle Management Software Market
Global Vascular Tissue Matrix Market Research Report 2024
Global Cardiac Medical Devices Market Research Report 2024
Global Angio Seal Devices Market Research Report 2025
Global Regenerative Medicine Products Market Research Report 2025
Global 0 Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions